Please use this identifier to cite or link to this item: /library/oar/handle/123456789/139309
Title: ±«²Ô»å±ð°ù²õ³Ù²¹²Ô»å¾±²Ô²µ&#³æ20;»å´Ç±è²¹³¾¾±²Ô±ð’s&#³æ20;°ù´Ç±ô±ð&#³æ20;¾±²Ô&#³æ20;²Ô±ð³Ü°ù´Ç±ô´Ç²µ¾±³¦²¹±ô&#³æ20;²¹²Ô»å&#³æ20;±è²õ²â³¦³ó¾±²¹³Ù°ù¾±³¦&#³æ20;»å¾±²õ´Ç°ù»å±ð°ù²õ
Authors: Blundell, Renald
Arslan, Lara
Keywords: Dopamine
Neurotransmitters
Parkinson's disease
Schizophrenia -- Pathophysiology
Bipolar disorder -- Pathophysiology
Movement disorders -- Treatment
Issue Date: 2025-09
Publisher: Standard Publications Ltd.
Citation: Blundell, R., & Arslan, L. (2025, September 28). ±«²Ô»å±ð°ù²õ³Ù²¹²Ô»å¾±²Ô²µ&#³æ20;»å´Ç±è²¹³¾¾±²Ô±ð’s&#³æ20;°ù´Ç±ô±ð&#³æ20;¾±²Ô&#³æ20;²Ô±ð³Ü°ù´Ç±ô´Ç²µ¾±³¦²¹±ô&#³æ20;²¹²Ô»å&#³æ20;±è²õ²â³¦³ó¾±²¹³Ù°ù¾±³¦&#³æ20;»å¾±²õ´Ç°ù»å±ð°ù²õ. The Malta Independent on Sunday, p. 22.
Abstract: Dopamine, a key neurotransmitter in the brain, plays a vital role in regulating movement, emotion, and cognition. It is central to the pathology of several major neurological and psychiatric disorders, including Parkinson's disease, schizophrenia, and bipolar disorder. These conditions, though distinct in their symptoms and progression, share a common feature: the disruption of dopamine signalling pathways. Understanding how dopamine dysfunction contributes to these disorders provides insight into their underlying mechanisms and guides the development of effective treatments.
URI: https://www.um.edu.mt/library/oar/handle/123456789/139309
Appears in Collections:Scholarly Works - FacM&SPB



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.